Lynn Baglyos

595 total citations
7 papers, 319 citations indexed

About

Lynn Baglyos is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lynn Baglyos has authored 7 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 4 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Lynn Baglyos's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (3 papers) and vaccines and immunoinformatics approaches (2 papers). Lynn Baglyos is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (3 papers) and vaccines and immunoinformatics approaches (2 papers). Lynn Baglyos collaborates with scholars based in United States, Uganda and Mexico. Lynn Baglyos's co-authors include Sanjay Gurunathan, Jim Tartaglia, Stanley A. Plotkin, Genoveffa Franchini, Raphaëlle El Habib, Lawrence Corey, Robert Paris, Arthur E. Brown, Chitraporn Karnasuta and Chirasak Khamboonruang and has published in prestigious journals such as Vaccine, JAIDS Journal of Acquired Immune Deficiency Syndromes and Expert Review of Vaccines.

In The Last Decade

Lynn Baglyos

7 papers receiving 311 citations

Peers

Lynn Baglyos

VIROL

IMMUN

EPIDE

ID

MB

Frederic M.N. Bertley Canada

M. Juliana McElrath United States

Tumelo Mashishi United Kingdom

Yanling Hao China

Jori Symons Australia

C Fracasso Italy

Laura Novik United States

V. Feuillie France

John D. Ventura United States

Jakub Kopycinski United Kingdom

Frederic M.N. Bertley Canada

Lynn Baglyos

211 ×0.8

VIROL

210 ×1.4

IMMUN

133 ×1.2

EPIDE

60 ×0.7

ID

74 ×0.8

MB

Citations per year, relative to Lynn Baglyos Lynn Baglyos (= 1×) peers Frederic M.N. Bertley

Countries citing papers authored by Lynn Baglyos

Since Specialization

Citations

This map shows the geographic impact of Lynn Baglyos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Baglyos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Baglyos more than expected).

Fields of papers citing papers by Lynn Baglyos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Baglyos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Baglyos. The network helps show where Lynn Baglyos may publish in the future.

Co-authorship network of co-authors of Lynn Baglyos

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Baglyos. A scholar is included among the top collaborators of Lynn Baglyos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Baglyos. Lynn Baglyos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kaleebu, Pontiano, Harr Freeya Njai, Lei Wang, et al.. (2013). Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027). JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3). 268–277. 9 indexed citations

2.

Kintu, Kenneth, P. Andrew, Philippa Musoke, et al.. (2012). Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV-Exposed Infants in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1). 1–8. 17 indexed citations

3.

Gandhi, Rajesh T., David O’Neill, Ronald J. Bosch, et al.. (2009). A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 27(43). 6088–6094. 67 indexed citations

4.

Gurunathan, Sanjay, Raphaëlle El Habib, Lynn Baglyos, et al.. (2009). Use of predictive markers of HIV disease progression in vaccine trials. Vaccine. 27(14). 1997–2015. 16 indexed citations

5.

Thongcharoen, P, Vinai Suriyanon, Robert Paris, et al.. (2007). A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 48–55. 67 indexed citations

6.

Russell, Nina D., Barney S. Graham, Michael C. Keefer, et al.. (2006). Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 203–212. 69 indexed citations

7.

Franchini, Genoveffa, Sanjay Gurunathan, Lynn Baglyos, Stanley A. Plotkin, & Jim Tartaglia. (2004). Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors. Expert Review of Vaccines. 3(sup1). S75–S88. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact